Yogen Saunthararajah, MD

• Service on National Institutes of Health, Veterans Administration, and Department of Defense Grant Review Committees and Advisory Boards
• Awarded grants by the National Institutes of Health, the Department of Defense and the Leukemia and Lymphoma Society

• Completed course work for Duke/NIH Master's in Clinical Research

• Graduated with Distinctions in Medicine and Surgery
• Received Excellence Awards from the University of Hawaii and University of Illinois at Chicago
• Grant awards from the National Institutes of Health and U.S. Department of Defense

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2025-04-16, Dr. Saunthararajah has reported the financial relationships with the companies listed below.

Equity Dr. Saunthararajah owns stock or stock options in the following companies for activities as a founder, inventor, discoverer, developer:

• EpiDestiny, Inc.
• Treebough Therapies, LLC

Fiduciary Role. Dr. Saunthararajah serves in a fiduciary capacity, such as an elected officer, director or chief medical officer, for the following companies or other entities:

• Treebough Therapies, LLC
• EpiDestiny, Inc.

Royalty Payments. Dr. Saunthararajah receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

• Novo Nordisk, A/S
• University of Illinois, Chicago
• EpiDestiny, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.